collaborative community studies of swine origin infuenza virus H1N1 (360G-Wellcome-091011_Z_09_A)
To provide timely information on The occurrence of ILI and of PCR confirmed influenza in different population subgroups. Clinical illness in symptomatic patients including range, duration and severity of symptoms and sensitivity and specificity of symptoms and fever. Access to care and treatment (experience of helplines, access to antivirals, treatment with antibiotics) Effectiveness of antivirals delivered through NHS Uptake and effectiveness of pandemic vaccine delivered through NHS Household secondary attack rates and serial interval. Population behaviour changes through the pandemic and during illness. To provide a representative control group for case control studies of severe disease. To provide a human DNA bank for future studies of genetic susceptibility. To provide a virus bank for studies of viral evolution as it transmits through households and different geographic areas.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
Amount Awarded | 78376 |
Applicant Surname | Hayward |
Approval Committee | Immunology and Infectious Disease Funding Committee |
Award Date | 2009-09-30T00:00:00+00:00 |
Financial Year | 2008/09 |
Grant Programme: Title | Project Grant |
Internal ID | 091011/Z/09/A |
Lead Applicant | Prof Andrew Hayward |
Partnership Name | Swine Flu |
Partnership Value | 78376 |
Planned Dates: End Date | 2010-09-30T00:00:00+00:00 |
Planned Dates: Start Date | 2009-10-01T00:00:00+00:00 |
Recipient Org: Country | United Kingdom |
Region | Greater London |